The cardiovascular assessment of patients undergoing noncardiacsurgery has been intensively investigated over the past 10 years.These studies have culminated in guidelines recently publishedby a joint task force of the American College of Cardiologyand the American Heart Association.1 On the basis of a reviewof the current scientific evidence, several principles of perioperativeevaluation and management have emerged.
First, clinical markers identifiable during a careful preoperativehistory-taking, physical examination, and review of the chestfilm and electrocardiogram are extremely useful in estimatingboth the perioperative and the long-term cardiac risk. The riskis highest among patients with . . . [Full Text of this Article]
References
This article has been cited by other articles:
HARTE, B., JAFFER, A. K.
(2008). Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence. Cleveland Clinic Journal of Medicine
75: 513-519
[Abstract][Full Text]
Selzman, C. H., Miller, S. A., Zimmerman, M. A., Harken, A. H.
(2001). The Case for {beta}-Adrenergic Blockade as Prophylaxis Against Perioperative Cardiovascular Morbidity and Mortality. Arch Surg
136: 286-290
[Abstract][Full Text]
Lee, T. H., Marcantonio, E. R., Mangione, C. M., Thomas, E. J., Polanczyk, C. A., Cook, E. F., Sugarbaker, D. J., Donaldson, M. C., Poss, R., Ho, K. K. L., Ludwig, L. E., Pedan, A., Goldman, L.
(1999). Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery. Circulation
100: 1043-1049
[Abstract][Full Text]